Cargando…
IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way
BACKGROUND: Insulin-like growth factor 2 (IGF2) messenger RNA binding protein 3 (IMP3) has been testified to be overexpressed in prostate cancer and strongly related to patients’ poor prognosis. However, the functions of IMP3 and the underlying mechanisms in prostate cancer still remain unknown. The...
Autores principales: | Zhang, Xiang, Wang, Dawei, Liu, Boke, Jin, Xingwei, Wang, Xianjin, Pan, Junwei, Tu, Weichao, Shao, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493339/ https://www.ncbi.nlm.nih.gov/pubmed/32938489 http://dx.doi.org/10.1186/s13046-020-01657-0 |
Ejemplares similares
-
Retraction Note: IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way
por: Zhang, Xiang, et al.
Publicado: (2023) -
Outcomes of ureteroscopy and internal ureteral stent for pregnancy with urolithiasis: a systematic review and meta-analysis
por: Jin, Xingwei, et al.
Publicado: (2022) -
Smurf1 Suppression Enhances Temozolomide Chemosensitivity in Glioblastoma by Facilitating PTEN Nuclear Translocation
por: Dong, Lei, et al.
Publicado: (2022) -
Initial satisfying experience of total retroperitoneal laparoscopic radical nephroureterectomy: a retrospective comparative research
por: Wang, Xianjin, et al.
Publicado: (2022) -
IL-23 and PSMA-targeted duo-CAR T cells in Prostate Cancer Eradication in a preclinical model
por: Wang, Dawei, et al.
Publicado: (2020)